Correlation Engine 2.0
Clear Search sequence regions


  • ADR (4)
  • adriamycin (1)
  • annexin (1)
  • apoptosis (5)
  • breast cancer (5)
  • breast carcinoma (1)
  • breast neoplasms (1)
  • cancer (1)
  • caspases (3)
  • cell (11)
  • cell cycle (4)
  • cell death (1)
  • cucurbitacin d (10)
  • cytosol (1)
  • d cell (1)
  • doxorubicin (9)
  • factor (2)
  • female (1)
  • g2 phase (1)
  • gene (2)
  • human (2)
  • i kappa b proteins (2)
  • iκb (1)
  • MCF7 (4)
  • mtt (1)
  • NF kappaB (1)
  • NF κB (10)
  • nucleus (2)
  • patients (1)
  • propidium (1)
  • protein human (1)
  • signal (1)
  • STAT3 (10)
  • stat3 protein (1)
  • triterpenes (2)
  • western blot (1)
  • women (2)
  • Sizes of these terms reflect their relevance to your search.

    Breast cancer is the most common cancer for women and is a major cause of mortality in women. Doxorubicin is a generally used chemotherapy drug for breast cancer. However, multidrug resistance of breast cancer interferes with the chemotherapy. We examined whether cucurbitacin D affects doxorubicin resistance of MCF7/ADR breast cancer cells. Cell viability was measured by MTT assay. Levels of p-STAT3, p-NF-κB, IκB, and caspases were measured by Western blot analysis. Nuclear staining of Stat3 and NF-κB was measured by immunocytochemistry. STAT3 and NF-κB transcriptional activity was detected by STAT3 and NF-κB luciferase reporter gene assays. Analysis of cell cycle arrest was performed by flow cytometry. Induction of apoptosis by cucurbitacin D was measured by Annexin V-FITC/propidium iodide assay. More than 90% of MCF7/ADR cells lived upon treatment with doxorubicin for 24 h. However, upon treatment with cucurbitacin D, cell death was more than 60%. Co-administration of cucurbitacin D and doxorubicin induced apoptosis, and G2/M cell cycle arrest, and inhibited upregulated Stat3 by doxorubicin on MCF7/ADR cells. Additionally, cucurbitacin D led to an increase in the IκBα level in the cytosol and a decrease in the p-NF-κB level in the nucleus. Finally, cucurbitacin D inhibited translocation of Stat3 and NF-κB and decreased transcriptional activity in the nucleus. Cucurbitacin D decreases cell proliferation and induces apoptosis by inhibiting Stat3 and NF-κB signaling in doxorubicin-resistant breast cancer cells. Cucurbitacin D could be used as a useful compound to treat adriamycin-resistant patients.

    Citation

    Jin Mo Ku, Soon Re Kim, Se Hyang Hong, Han-Seok Choi, Hye Sook Seo, Yong Cheol Shin, Seong-Gyu Ko. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells. Molecular and cellular biochemistry. 2015 Nov;409(1-2):33-43

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 26169986

    View Full Text